Shopping Cart 0
Cart Subtotal
USD 0

Express Scripts Holding Co (ESRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Express Scripts Holding Company (Express Scripts) is a pharmacy benefit management (PBM) company. It provides integrated pharmacy-benefit management services such as home delivery pharmacy services, specialty benefit management, network-pharmacy claims processing, formulary management, and medical and drug data analysis services. It also distributes a wide range of biopharmaceutical products and prescription drugs for specialty and orphan diseases; and provides cost-management and patient-care services. Express Scripts caters its services to clinics, managed care organizations, providers, hospitals, employers, union-sponsored benefit plans, health insurers, third-party administrators, workers' compensation plans and government health programs. Express Scripts is headquartered in St. Louis, Missouri, the US.

Express Scripts Holding Co (ESRX)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Express Scripts Holding Co, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Express Scripts Holding Co, Medical Devices Deals, 2012 to YTD 2018 10

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deal Details 12

Private Equity 12

Avista Capital Partners to Acquire United BioSource from Express Scripts 12

Parthenon Capital Acquires Bracket Global From Express Scripts 13

Symphony Technology Acquires Market Access And Data Analytics Divisions Of United BioSource 14

Halifax Group Completes Management Buyout Of Envision Pharma 15

Express Scripts Receives Offer From TRC Capital To Acquire 0.24% Stake For Up To USD 112 Million 16

ABS Capital Acquires ConnectYourCare From Express Scripts 17

Debt Offering 18

Express Scripts Completes Private Placement Of Senior Notes Due 2017 For USD 1.5 Billion 18

Express Scripts Completes Private Placement Of Senior Notes Due 2022 For USD 1 Billion 19

Express Scripts Completes Private Placement Of Senior Notes Due 2015 For USD 1 Billion 20

Acquisition 21

Express Scripts Completes Acquisition Of Medco Health For USD 29 Billion 21

Express Scripts Holding Co-Key Competitors 23

Express Scripts Holding Co-Key Employees 24

Express Scripts Holding Co-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Recent Developments 28

Strategy And Business Planning 28

Jul 18, 2018: Express Scripts Subsidiary Expands Services to Healthcare Providers, Adding 100 Jobs in St. Louis 28

Financial Announcements 29

Oct 31, 2018: Express Scripts announces 2018 third quarter results 29

Aug 01, 2018: Express Scripts announces 2018 second quarter results 31

May 02, 2018: Express Scripts Reports 2018 First Quarter Financial Results 33

Feb 27, 2018: Express Scripts Announces 2017 Fourth Quarter and Full Year Results 35

Oct 24, 2017: Express Scripts Announces 2017 Third Quarter Results 37

Jul 25, 2017: Express Scripts Announces 2017 Second Quarter Results 38

Apr 24, 2017: Express Scripts Announces 2017 First Quarter Results 39

Feb 14, 2017: Express Scripts Announces 2016 Fourth Quarter and Full Year Results 40

Corporate Communications 41

Oct 09, 2018: Express Scripts readies emergency support for impacted members in advance of Hurricane Michael 41

Sep 27, 2018: Cigna announces enterprise leadership team for combined company 42

Apr 03, 2018: Express Scripts appoints Ron Guerrier as chief information officer 43

Oct 24, 2017: Express Scripts Appoints James M. Havel Chief Financial Officer 44

Jun 27, 2017: Express Scripts Elects Kathleen M. Mazzarella to Board of Directors 45

Legal and Regulatory 46

Jun 25, 2018: Pharmacy First Files Suit Against Express Scripts 46

Jan 10, 2018: Express Scripts Accredo Earns Renewed URAC Specialty Pharmacy Accreditation 47

Government and Public Interest 48

May 11, 2018: Express Scripts Statement on Administration's Comments on Drug Pricing 48

Aug 25, 2017: Express Scripts Research Shows Significant Benefit of Adherence to Diabetes Medications 49

Product News 50

Nov 06, 2018: Express Script' myMatrixx launches myDataSense analytics tool 50

Other Significant Developments 51

Oct 17, 2018: Express scripts offers new value-based program for migraine 51

Oct 09, 2018: Express Scripts Introduces Medicare Part D Plan Offerings for 2019 52

Sep 12, 2018: Express Scripts implements emergency procedures for affected members in advance of hurricane florence 53

May 10, 2018: Innovative Value-based SafeGuardRx Program Delivers Better Care at Lower Cost for Express Scripts' Patients and Plan Sponsors 54

May 03, 2018: Inside Rx, a Prescription Savings Program from Express Scripts, Expands List of Discounted Brand-Name Medications 55

Apr 12, 2018: Express Scripts Launches Innovative Pilot Program For Performance-based Retail Pharmacy Network for Commercial Plans 56

Feb 05, 2018: Inside Rx Provides Savings on Influenza Medications 57

Jan 11, 2018: Safer Opioid Prescribing: Express Scripts Significantly Reduces Inappropriate Selection and Excessive Dispensing of Opioids for New Patients 58

Oct 02, 2017: Express Scripts Introduces New Medicare Part D Saver Plan for 2018 60

Jun 07, 2017: Express Scripts Introduces Comprehensive Solution to Reduce Opioid Abuse 61

Jun 01, 2017: Express Scripts Expands SafeGuardRx Program to Improve Care for Pulmonary Conditions and Multiple Sclerosis 62

Appendix 64

Methodology 64

About GlobalData 64

Contact Us 64

Disclaimer 64


List Of Figure

List of Figures

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Express Scripts Holding Co, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Express Scripts Holding Co, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Express Scripts Holding Co, Deals By Therapy Area, 2012 to YTD 2018 9

Express Scripts Holding Co, Medical Devices Deals, 2012 to YTD 2018 10

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Avista Capital Partners to Acquire United BioSource from Express Scripts 12

Parthenon Capital Acquires Bracket Global From Express Scripts 13

Symphony Technology Acquires Market Access And Data Analytics Divisions Of United BioSource 14

Halifax Group Completes Management Buyout Of Envision Pharma 15

Express Scripts Receives Offer From TRC Capital To Acquire 0.24% Stake For Up To USD 112 Million 16

ABS Capital Acquires ConnectYourCare From Express Scripts 17

Express Scripts Completes Private Placement Of Senior Notes Due 2017 For USD 1.5 Billion 18

Express Scripts Completes Private Placement Of Senior Notes Due 2022 For USD 1 Billion 19

Express Scripts Completes Private Placement Of Senior Notes Due 2015 For USD 1 Billion 20

Express Scripts Completes Acquisition Of Medco Health For USD 29 Billion 21

Express Scripts Holding Co, Key Competitors 23

Express Scripts Holding Co, Key Employees 24

Express Scripts Holding Co, Subsidiaries 26

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Express Scripts Holding Co, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Express Scripts Holding Company (Express Scripts) is a pharmacy benefit management (PBM) company. It provides integrated pharmacy-benefit management services such as home delivery pharmacy services, specialty benefit management, network-pharmacy claims processing, formulary management, and medical and drug data analysis services. It also distributes a wide range of biopharmaceutical products and prescription drugs for specialty and orphan diseases; and provides cost-management and patient-care services. Express Scripts caters its services to clinics, managed care organizations, providers, hospitals, employers, union-sponsored benefit plans, health insurers, third-party administrators, workers' compensation plans and government health programs. Express Scripts is headquartered in St. Louis, Missouri, the US.

Express Scripts Holding Co (ESRX)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Express Scripts Holding Co, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Express Scripts Holding Co, Medical Devices Deals, 2012 to YTD 2018 10

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deal Details 12

Private Equity 12

Avista Capital Partners to Acquire United BioSource from Express Scripts 12

Parthenon Capital Acquires Bracket Global From Express Scripts 13

Symphony Technology Acquires Market Access And Data Analytics Divisions Of United BioSource 14

Halifax Group Completes Management Buyout Of Envision Pharma 15

Express Scripts Receives Offer From TRC Capital To Acquire 0.24% Stake For Up To USD 112 Million 16

ABS Capital Acquires ConnectYourCare From Express Scripts 17

Debt Offering 18

Express Scripts Completes Private Placement Of Senior Notes Due 2017 For USD 1.5 Billion 18

Express Scripts Completes Private Placement Of Senior Notes Due 2022 For USD 1 Billion 19

Express Scripts Completes Private Placement Of Senior Notes Due 2015 For USD 1 Billion 20

Acquisition 21

Express Scripts Completes Acquisition Of Medco Health For USD 29 Billion 21

Express Scripts Holding Co-Key Competitors 23

Express Scripts Holding Co-Key Employees 24

Express Scripts Holding Co-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Recent Developments 28

Strategy And Business Planning 28

Jul 18, 2018: Express Scripts Subsidiary Expands Services to Healthcare Providers, Adding 100 Jobs in St. Louis 28

Financial Announcements 29

Oct 31, 2018: Express Scripts announces 2018 third quarter results 29

Aug 01, 2018: Express Scripts announces 2018 second quarter results 31

May 02, 2018: Express Scripts Reports 2018 First Quarter Financial Results 33

Feb 27, 2018: Express Scripts Announces 2017 Fourth Quarter and Full Year Results 35

Oct 24, 2017: Express Scripts Announces 2017 Third Quarter Results 37

Jul 25, 2017: Express Scripts Announces 2017 Second Quarter Results 38

Apr 24, 2017: Express Scripts Announces 2017 First Quarter Results 39

Feb 14, 2017: Express Scripts Announces 2016 Fourth Quarter and Full Year Results 40

Corporate Communications 41

Oct 09, 2018: Express Scripts readies emergency support for impacted members in advance of Hurricane Michael 41

Sep 27, 2018: Cigna announces enterprise leadership team for combined company 42

Apr 03, 2018: Express Scripts appoints Ron Guerrier as chief information officer 43

Oct 24, 2017: Express Scripts Appoints James M. Havel Chief Financial Officer 44

Jun 27, 2017: Express Scripts Elects Kathleen M. Mazzarella to Board of Directors 45

Legal and Regulatory 46

Jun 25, 2018: Pharmacy First Files Suit Against Express Scripts 46

Jan 10, 2018: Express Scripts Accredo Earns Renewed URAC Specialty Pharmacy Accreditation 47

Government and Public Interest 48

May 11, 2018: Express Scripts Statement on Administration's Comments on Drug Pricing 48

Aug 25, 2017: Express Scripts Research Shows Significant Benefit of Adherence to Diabetes Medications 49

Product News 50

Nov 06, 2018: Express Script' myMatrixx launches myDataSense analytics tool 50

Other Significant Developments 51

Oct 17, 2018: Express scripts offers new value-based program for migraine 51

Oct 09, 2018: Express Scripts Introduces Medicare Part D Plan Offerings for 2019 52

Sep 12, 2018: Express Scripts implements emergency procedures for affected members in advance of hurricane florence 53

May 10, 2018: Innovative Value-based SafeGuardRx Program Delivers Better Care at Lower Cost for Express Scripts' Patients and Plan Sponsors 54

May 03, 2018: Inside Rx, a Prescription Savings Program from Express Scripts, Expands List of Discounted Brand-Name Medications 55

Apr 12, 2018: Express Scripts Launches Innovative Pilot Program For Performance-based Retail Pharmacy Network for Commercial Plans 56

Feb 05, 2018: Inside Rx Provides Savings on Influenza Medications 57

Jan 11, 2018: Safer Opioid Prescribing: Express Scripts Significantly Reduces Inappropriate Selection and Excessive Dispensing of Opioids for New Patients 58

Oct 02, 2017: Express Scripts Introduces New Medicare Part D Saver Plan for 2018 60

Jun 07, 2017: Express Scripts Introduces Comprehensive Solution to Reduce Opioid Abuse 61

Jun 01, 2017: Express Scripts Expands SafeGuardRx Program to Improve Care for Pulmonary Conditions and Multiple Sclerosis 62

Appendix 64

Methodology 64

About GlobalData 64

Contact Us 64

Disclaimer 64


List Of Figure

List of Figures

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Express Scripts Holding Co, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Express Scripts Holding Co, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Express Scripts Holding Co, Deals By Therapy Area, 2012 to YTD 2018 9

Express Scripts Holding Co, Medical Devices Deals, 2012 to YTD 2018 10

Express Scripts Holding Co, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Avista Capital Partners to Acquire United BioSource from Express Scripts 12

Parthenon Capital Acquires Bracket Global From Express Scripts 13

Symphony Technology Acquires Market Access And Data Analytics Divisions Of United BioSource 14

Halifax Group Completes Management Buyout Of Envision Pharma 15

Express Scripts Receives Offer From TRC Capital To Acquire 0.24% Stake For Up To USD 112 Million 16

ABS Capital Acquires ConnectYourCare From Express Scripts 17

Express Scripts Completes Private Placement Of Senior Notes Due 2017 For USD 1.5 Billion 18

Express Scripts Completes Private Placement Of Senior Notes Due 2022 For USD 1 Billion 19

Express Scripts Completes Private Placement Of Senior Notes Due 2015 For USD 1 Billion 20

Express Scripts Completes Acquisition Of Medco Health For USD 29 Billion 21

Express Scripts Holding Co, Key Competitors 23

Express Scripts Holding Co, Key Employees 24

Express Scripts Holding Co, Subsidiaries 26

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Express Scripts Holding Co, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.